Drug Profile
Research programme: beta-elemene nano-emulsion formulation - ADVENTRX Pharmaceuticals
Alternative Names: ANX 570; Beta-elemene - ADVENTRX Pharmaceuticals; Elemene - ADVENTRX Pharmaceuticals; SDP-111; β-elemene - ADVENTRX PharmaceuticalsLatest Information Update: 30 Oct 2008
Price :
$50
*
At a glance
- Originator ADVENTRX Pharmaceuticals
- Class Antineoplastics; Sesquiterpenes; Small molecules
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 30 Jan 2007 ANX 570 is available for licensing (http://www.adventrx.com)
- 28 Apr 2006 SD Pharmaceuticals has been acquired by ADVENTRX Pharmaceuticals
- 12 Apr 2006 Preclinical trials in Cancer in USA (IV)